在类风湿性关节炎和全身性红斑狼中加速动脉样硬化的免疫调节
Elena Bartoloni1, Fabio Cacciapaglia2, Gian Luca Erre3
1Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Italy.
Autoimmunity reviews
|February 2, 2025
概括
诸如类风湿性关节炎和全身性红斑狼之类的自身免疫性疾病通过免疫路径加速心血管疾病. 免疫抑制疗法可以减轻这种动脉样硬化风险.
科学领域:
- 心血管医学 心血管医学
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 自免疫性疾病,包括类风湿性关节炎 (RA) 和全身性红斑狼 (SLE),与加速的心血管 (CV) 疾病有关.
- 免疫细胞和炎症性细胞因子与这些患者的早期动脉样硬化损伤有关.
- 传统的心血管风险因素不能完全解释RA和SLE中心血管疾病患病率的增加.
研究的目的:
- 审查RA和SLE发病过程中免疫和炎症途径的动脉动脉效应.
- 检查免疫抑制疗法减少心血管损伤和这些患者的风险的证据.
主要方法:
- 关于RA/SLE和动脉样硬化的免疫路径研究的文献综述.
- 关于免疫抑制治疗和心血管结果的证据分析.
主要成果:
- 免疫和炎症途径显著导致RA和SLE中的动脉样硬化.
- 免疫抑制药物可能具有有益于心血管健康的免疫调节和抗炎性质.
- 早期干预和风险因素识别对于预防RA和SLE患者的心血管疾病至关重要.
结论:
- 自免疫性疾病发病和动脉样硬化之间的相互作用是复杂的,并由炎症驱动.
- 免疫抑制疗法是减少RA和SLE中心血管疾病发病率和死亡率的潜在策略.
- 进一步的研究是有必要的,以优化心血管风险管理在患有自身免疫疾病的患者.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
T Cell Types and Functions
939
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
939
Autoimmune Disorders
379
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
379
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Inflammatory Response
1.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.8K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114


